TECH OFFERS

Reimagining how healthcare data is analyzed, this platform enables advanced data science without moving a single byte of patient data. Designed from the ground up to comply with global privacy regulations, it allows hospitals and research institutions to develop powerful AI models using real-world clinical data—while keeping that data entirely on-site under governance. Powered by proprietary federated learning and a modular AI/ML development toolkit, the platform solves one of healthcare’s biggest bottlenecks: secure access to data for innovation. With seamless integration into existing IT systems and end-to-end compliance with GDPR and HIPAA, this is the infrastructure for the future of privacy-first, multi-institutional healthcare data analytics and AI/ML. The technology owner is actively seeking collaboration with healthcare providers, research institutions, clinical research organizations, and data-centric health-tech companies eager to scale innovation—without compromising privacy or control. The platform is an advanced, modular software framework comprising secure data integration pipelines, federated learning capabilities and real-time analytics tools. Its key components include: Federated Learning Infrastructure: Enabling multi-centre data collaboration without transferring sensitive data. AI/ML Model Development Suite: Customizable tools for predictive analytics tailored to healthcare needs. Interoperability APIs: Seamless integration with existing health IT systems. Advanced Security Protocols: End-to-end encryption and compliance with global data protection standards. The platform is a versatile platform purpose-built to power a broad spectrum of data-driven healthcare applications. It supports not only advanced medical research, but also the development of AI/ML solutions for diagnostics and clinical decision support across any medical domain, as well as AI-powered population health management and precision medicine initiatives. Its capabilities extend to clinical trial analytics—such as simulation, and optimization — and the integration of complex healthcare datasets, including genomic and real-world data. With its privacy-first federated learning architecture, the platform enables secure, multi-institutional collaboration without transferring or centralizing sensitive data. This makes it especially valuable for high-impact use cases like rare disease research, where combining insights from multiple centers across the globe can overcome single center data limitations and drive meaningful discoveries. The platform has been successfully deployed at Seoul National University Bundang Hospital (SNUBH) to support the development of real-world clinical AI models—demonstrating its readiness for mission-critical healthcare environments. One key application was in building an AI model to predict comorbidity risks in patients with type 2 diabetes, enabling proactive clinical intervention for conditions such as cardiovascular disease, kidney failure, and diabetic retinopathy. In a separate initiative, the platform powered the development of an AI-based antibiotic stewardship model—replacing what is typically a manual, labor-intensive process. Traditionally, stewardship programs require clinicians to retrospectively review patient records to detect inappropriate antibiotic use. With the platform, diverse clinical datasets were securely integrated and analyzed on-site, allowing the AI to flag high-risk patients in near real time. The result was a significant reduction in manual workload, faster clinical decision-making, and improved program scalability. These real-world deployments underscore the platform’s ability to accelerate healthcare innovation while maintaining full data privacy and governance.   Privacy-Preserving by Design: Enables AI development and collaboration without transferring or centralizing patient data — ensuring full compliance and trust. Built for Real-World Healthcare with Flexibility and Scalability: Deployable on cloud or on-prem, Enobase adapts to diverse data environments and project needs — scaling effortlessly to support anything from single-site pilots to multi-institutional collaborations. Accelerates Scalable Innovation: Powers rapid development and deployment of AI for diagnostics, population health, and clinical decision support — across institutions and borders.     Healthcare Data Science, Federated Learning, AI/ML, Data Privacy, Medical Analytics, Secure Data Infrastructure, Data Platform, Cloud Agnostic Healthcare, Medical Devices, Telehealth, Medical Software & Imaging, Infocomm, Healthcare ICT

Early detection of Mild Cognitive Impairment (MCI), especially the vascular subtype, is becoming increasingly important as populations age and the burden of dementia rises globally. Approximately 12% to 18% of people age 60 or older are living with MCI, and an estimated 10% to 15% of individuals living with MCI develop dementia each year — many of which could benefit from timely intervention to slow or prevent further cognitive decline. This digital solution offers a non-invasive, self-administered cognitive screening tool that can be completed in just 15 minutes via a mobile device or tablet. It uses a series of interactive, neuroscience-informed digital tasks to assess multiple cognitive functions, including working memory, attention, processing speed, and executive function. These areas are particularly relevant in identifying different subtypes of MCI, such as those related to vascular causes. The system’s proprietary algorithm analyzes the user’s performance and has been clinically validated in Southeast Asia, achieving 89% accuracy with strong specificity and sensitivity. Its objective, performance-based design makes it suitable for deployment across various healthcare settings—from hospitals and clinics to insurers and community screening programs. By offering a quick, engaging, and scalable method for cognitive screening, this solution supports earlier identification of cognitive changes and provides actionable insights that can help guide appropriate follow-up care based on the individual’s cognitive profile. At the heart of the solution is a suite of neuroscience-backed digital games, purpose-built to evaluate key cognitive domains—working memory, attention, processing speed, and executive function. These interactive tasks generate performance data processed by a proprietary classification algorithm. Clinically validated in Southeast Asia through a study involving 250 participants, the tool demonstrated a classification accuracy of 89%, with specificity and sensitivity rates of 83% and 85% respectively. This solution can be widely adopted across various healthcare ecosystems, including: Hospitals GP clinics  Healthcare insurance providers Wellness centres  It also opens up opportunities for commercial products such as corporate cognitive wellness programs and dementia-specific insurance plans, enhancing value propositions for insurers and health-focused employers alike. Current MCI detection methods typically rely on MRIs and detailed neuropsychological testing—both of which require trained personnel, extended patient interaction, and significant costs. In contrast, this digital tool provides: A self-administered test No need for specialist oversight Completion in under 15 minutes An engaging, gamified interface The result is a highly scalable and accessible cognitive screening method that maintains clinical rigour while ensuring ease of use and user engagement—crucial for widespread adoption in diverse populations. Dementia, Mild Cognitive Impairment, Cognitive Health Healthcare, Diagnostics, Telehealth, Medical Software & Imaging

In a world where consumers expect fast, intuitive, and personalised interactions, traditional phone-based customer service systems often fall short—plagued by long wait times, clunky menus, and impersonal scripts. This Generative Voice AI technology offers a transformative alternative: highly localised, low-latency AI Voice Agents that communicate with human-like fluency, adapted to regional languages and accents including Singlish, Mandarin, Bahasa, and Malay. Built on a proprietary orchestration layer that integrates multiple advanced AI models—such as speech recognition, large language models, and natural speech synthesis—this solution delivers seamless, real-time voice interactions with remarkable accuracy and responsiveness. Not only can Voice AI Agents reduce call wait times to zero and improve customer satisfaction for companies, it can also do outbound sales and lead qualification to generate higher revenue. Beyond traditional roles, these Voice AI Agents are also redefining interactive experiences across industries. Imagine a multilingual guide replacing static audio tours in museums and travel hotspots, or a virtual assistant enhancing patient navigation in healthcare settings. In gaming, they enable real-time, unscripted conversations with non-player characters (NPCs), adding depth and realism to gameplay and storytelling. These are not just voice interfaces—they're intelligent conversational agents. The tech owner seeks industry partners and system integrators to embed their proprietary technology into pre-existing software to add value and transform customer experience in sectors such as F&B, Healthcare, Marketing, Tourism, E-Commerce, Hospitality, Insurance, Financial Services, Gaming etc. Cascading ASR System: Integrates speech-to-text, LLMs, text-to-speech, and contextual models to simulate intelligent, fluent conversation. Telephony-Optimised: Ensures high call quality and response accuracy over phone lines. Proven Outcomes: Over 60% cost savings over human agents. Average 30% improvement in customer satisfaction. 10x increase in lead qualification and revenue-driving interactions. Customer Support & Sales Across industries such as financial services, insurance, e-commerce, education, BPOs, marketing, and hospitality, the AI Voice Agent automates high-volume interactions with natural, real-time conversations. It handles inbound support, outbound lead qualification, appointment setting, policy inquiries, and product recommendations—reducing manpower cost while improving satisfaction and conversion rates. Interactivity Enhancement The technology also opens up opportunities beyond conventional customer service, enhancing user engagement in more immersive and context-specific environments: Healthcare: Acts as a multilingual virtual assistant for patients—offering appointment reminders, explaining medical procedures in simple terms, guiding post-treatment care, and supporting chronic condition management. In clinical settings, it can function as a digital triage or nurse assistant, freeing up staff for higher-value tasks. Hospitality: Powers smart concierge agents capable of handling guest queries, local recommendations, service requests, and upselling—available 24/7 in the guest’s preferred language. Tourism: Replaces static audio tours with dynamic, conversational voice guides that adapt to visitor interests, languages, and local context. Education: Supports learning through AI-driven teaching assistants that respond to student queries, reinforce concepts, and provide explanations tailored to individual learning styles. Gaming: Enables interactive, unscripted voice conversations with non-player characters (NPCs), making game environments more immersive, responsive, and emotionally resonant. Where many voice bot platforms require deep technical know-how and still deliver robotic-sounding results, this Voice AI Agent flips the script. Its proprietary orchestration layer brings together the best of today’s AI ecosystem—streamlining complexity to deliver a natural-sounding, adaptive voice that feels like a real person on the other end. Unlike process-driven bots, this solution handles unstructured queries with intelligence, personality, and local linguistic flair—whether in Singlish, Mandarin, Bahasa, or beyond. It’s optimised for real-world usage, delivering results not just in ideal lab conditions, but on live phone calls with diverse users. Voice AI, Generative AI, Customer Service, Localised Language, Singlish Infocomm, Artificial Intelligence, Speech/Audio Analysis & Speech Recognition

This novel technology introduces a breakthrough self-assembly porous hydrogel platform that revolutionizes drug delivery, going far beyond the limitations of traditional static creams and non-porous emulsions. The unique porous hydrogel structure demonstrates an 85% increase in drug bioavailability through enhanced penetration and controlled release, compared to traditional formulations that create impermeable barriers. The innovative one-step drug delivery system achieves a 20-fold reduction in manufacturing costs by eliminating multiple complex steps typically required in conventional processes, such as vehicle manufacturing, formulation and purification. Through its distinctive porous architecture, this streamlined approach delivers enhanced therapeutic outcomes while maintaining production efficiency. Especially on eczema, this technology represents a breakthrough in treatment by addressing the multifactorial nature of the disease. Traditional eczema therapies typically target only one or two aspects of the condition, often leading to limited efficacy and undesirable side effects. In contrast, this delivery method enables the simultaneous modulation of several key pathological pathways. It specifically targets inflammation, oxidative stress, proteasome dysfunction, and ferroptosis while also enhancing skin barrier function—critical factors in both the onset and persistence of eczema. This potentially reduces flare-ups and improves overall skin health. This technology is applicable as an over-the-counter advanced topical formulation and as injectables. The technology provider is seeking the following collaborations: Co-development opportunities Patient centric non-profit organisations to support life-changing treatments. Dermatology focused clinics Formulation focused CRO/CDMO working on complex medicines Startup companies working on new modalities or novel API including oligo medicines AI/ML-driven drug discovery firms. Leverage predictive modeling to optimize key properties, such as porosity and drug loading ratios This advanced hydrogel drug delivery system employs an aqueous two-phase system (ATPS) to facilitate concurrent polymer self-assembly and active pharmaceutical ingredient (API) separation. Aqueous two-phase system: ATPS is a well-established method that selectively partitions molecules by mixing specific polymer pairs with target compounds in water, thereby creating two distinct phases. Separation of polymers and API: By carefully selecting the appropriate polymer pair, both the self-assembling polymers and APIs are maintained within the same phase, ensuring a higher localized concentration. Simultaneous self-assembly and encapsulation: This elevated concentration triggers the polymers to undergo self-assembly, effectively encapsulating the API without the need for additional chemical modifications or cross-linkers. Notably, the platform’s versatility lies in its independence from specific chemical interactions, enabling the encapsulation of a broad spectrum of APIs, including peptides, proteins, and small-molecule drugs. This IP meets the growing demand for safer, multifunctional eczema therapies. Key buyers include: Pharmaceutical companies seeking next-generation topical formulations to replace steroids or biologics (high cost, invasive administration). Dermatology-focused biotech firms interested in HA-based drug delivery platforms for inflammatory skin diseases. Consumer health brands aiming to develop over-the-counter skincare products with clinical efficacy. Innovative drug delivery platform addresses a critical unmet need in chronic skin conditions that affect over 355 million people worldwide. Traditional treatments have limited success—only about 30% remission—and come with high costs (£6,000–£14,000 per patient annually), while existing delivery systems offer a modest 5–15% drug bioavailability. The self-assembling porous hydrogel technology achieves three major breakthroughs: an impressive 85% bioavailability through superior drug penetration, a 72-hour sustained release profile, and the capability to deliver multiple therapeutic agents in a single formulation. The global dermatology therapeutics market, particularly for psoriasis and atopic dermatitis, is projected to reach $47 billion by 2027, growing at an 8.2% CAGR. This creates significant opportunities within key segments, such as the 125 million psoriasis patients seeking alternatives to biologics and the 230 million moderate-to-severe atopic dermatitis patients. This proprietary hyaluronic acid-based platform, with its optimized network structure, ensures unmatched drug penetration efficiency and controlled, prolonged release. This dual-action approach, which simultaneously targets inflammation, oxidative stress, and impaired barrier function, positions this technology as a disruptive alternative to current market leaders like biological therapies (45% market share) and topical corticosteroids (30%). This technology represents a paradigm shift in eczema and psorosis treatment by integrating multi-pathway targeting, sustained drug delivery, and biomimetic repair into a single hydrogel platform, overcoming critical limitations of current therapies. By delivering multiple therapeutic agents concurrently, this particular platform effectively addresses the multifaceted nature of conditions such as psoriasis and atopic dermatitis, which involve intertwined pathways like inflammation, oxidative stress, proteasome dysfunction, and barrier impairment. Key innovations include: • Multi-modal Targeting: Simultaneously addressing multiple disease mechanisms reduces the risk of treatment resistance and incomplete responses typical of single-pathway approaches. • Self-Assembling Porous Structure: An innovative, patent-protected two-phase system forms a stable network with uniform, adjustable pore sizes (10 nm to 4 μm). • Enhanced Penetration and Stability: The platform’s interconnected porous architecture creates a continuous gradient that maximizes API absorption while preserving drug stability under controlled conditions, ensuring sustained release (vs. short-acting creams) and reducing application frequency. • Risk Mitigation: Utilizing compounds with proven safety profiles streamlines regulatory approval by focusing innovation on the delivery system itself. By unifying symptom relief, root-cause modulation, and patient-centric design, this hydrogel offers a first-in-class solution for long-term eczema management, positioning it as a safer, more effective alternative to fragmented or invasive state-of-the-art options. Drug Delivery Platform, Hydrogel delivery, Hydrogel Encapsulation, Eczema, Chronic Skin Conditions, Pharmaceutical APIs Healthcare, Medical Devices, Pharmaceuticals & Therapeutics

This technology represents an innovative approach to indoor air quality (IAQ) management, focusing on sustainability and energy efficiency. Leveraging the principle of dilution, outdoor airflow can be adjusted dynamically to balance energy consumption and air quality. The system uses a predefined control algorithm to determine the optimal mix of outdoor and recirculated air based on the concentration of particulate matter or carbon dioxide in the indoor environment. Users can customise the system's operation based on their IAQ requirements, ensuring efficient ventilation while minimising energy usage. This low-cost solution aims to tackle challenges associated with IAQ, energy efficiency, and sustainability that cannot be accomplished by traditional heating, ventilation, and air conditioning (HVAC) systems. Instead, integrating decentralised air purification technologies into building design and urban planning initiatives, indoor pollutants can be removed while minimising operational costs and environmental impact. City planners can now better prioritise IAQ and energy efficiency from the outset, ensuring that future developments contribute to healthier, more livable communities. Public health, well-being, environmental sustainability, and climate resilience can be strengthened. This technology is best suited for retrofitting air conditioning systems in small to medium-sized residential care facilities and commercial buildings. This technology uses IAQ management to maintain consistent air quality, tailored to individual rooms or zones. With customisable airflow rates and purification levels, IAQ can be more effectively managed across the entire building. Additionally, integrating the Dilution Air Processing Unit (DAPU) enhances energy efficiency through process integration, engineered air psychrometry, and real-time monitoring and control. This significantly reduces energy consumption and operational costs compared to conventional HVAC systems. The novelty of this technology lies in its comprehensive approach to IAQ management, integrating engineering principles with advanced technologies to deliver tailored solutions for various building needs. Key features and performance data of DAPS include: Customisable fresh air intake: Gradually adjusts fresh air intake to maintain target PM1.0/PM2.5 levels. Activates 100% fresh air only when PM levels reach user-defined critical thresholds. Improved particle reduction efficiency: At a baseline ventilation requirement of 33% fresh air, DAPS reduces PM2.5 by 33%, compared to only 21% with traditional ACMV systems. At 100% fresh air, DAPS reduces PM2.5 by 79%, whereas traditional ACMV systems achieve only 51%. Better performance compared to air purifiers: Provides 10% higher PM2.5 particle reduction efficiency than standard air purifiers in similar room settings. Air purifiers do not meet SS554 fresh air requirements for buildings. Energy efficiency: When coupled with Dilution Air Processing Unit (DAPU), DAPS consumes 25% to 34% less energy across all fresh air settings than traditional ACMV systems. Critical environments such as hospitals and laboratories Commercial buildings requiring zone-level or room-level IAQ control Healthcare isolation and treatment facilities Hot-desking areas in airport terminals Hot-desking areas in shopping malls     Optimises energy efficiency by identifying the ideal fresh air percentage to achieve the desired air quality, ensuring energy savings and improved IAQ. Adapts purification levels in real-time to minimize unnecessary energy use while maintaining optimal air quality. Mitigates retrofitting issues for existing buildings by setting up easy-to-implement real-world examples. Incorporates advanced dynamic features that meet SS554 standards and outperform existing air cleaning technologies, including air purifiers and HEPA filters. Adopts a pollution-free, environmental-friendly approach for indoor air quality, aligning with global energy and environmental goal. The technology owner seeks to collaborate with: Building and transport system integrators to drive widespread adoption of DAPS. Healthcare institutions looking to upgrade their ventilation systems to reduce respiratory illnesses among vulnerable occupants. AI-based statisticians to analyse correlations among various factors and develop predictive models for reducing the spread of airborne diseases using DAPS data-driven systems. By integrating engineering, health sciences, and data science, the technology owner aims to develop comprehensive healthcare solutions for future advancements. Dilution ventilation, Air purification, Clean air technology, Indoor air quality management, Outdoor/ Fan Environment, Clean Air & Water, Sensor, Network, Monitoring & Quality Control Systems

This advanced AI art creation platform offers an efficient and accessible solution for generating high-quality digital artwork. Developed with the needs of artists, designers, and content creators in mind, the platform streamlines the creative process through key features such as text-to-image, image-to-image, text-to-video, and conditional image generation. By integrating state-of-the-art AI models with a user-friendly interface, it enables users to produce professional-grade visual content without the need for extensive technical expertise. The platform offers a comprehensive suite of AI-powered creative tools designed to enhance productivity and artistic expression. Key features include: Text-to-Image: Transforms written descriptions into high-quality visual content. Image-to-Image: Enhances and creatively modifies existing images. Text-to-Video: Converts text inputs into dynamic video sequences. Conditional Image Generation: Produces images based on specific inputs and parameters, offering greater control and precision. ComfyUI Workflow: Supports both pre-configured and customizable workflows on ComfyUI Cloud, enabling seamless and scalable AI art creation. Digital Canvas: A collaborative online environment for uploading, editing, and optimizing artworks, enhanced by intelligent automation and real-time customization. AI Tool Suite: Features include AI face swapping, AI-generated photo shoots, smart object removal, and advanced image enhancement tools. This platform is ideally suited for collaboration with digital content creators, media and advertising agencies, and educational institutions seeking innovative and efficient content creation solutions. The versatility of this AI art platform enables its deployment across a wide range of industries: Game Industry: Supports character design, iconography, and promotional banner creation. E-commerce: Enhances product presentation through model retouching and promotional image generation. Education: Facilitates the development of tutorial materials and visual content for online courses. Home Décor: Assists in creating marketing visuals and effect renderings for interior design products. Media & Entertainment: Powers the creation of virtual influencers and multimedia content. Industrial Design: Offers diverse and adaptable design concepts for prototyping and presentations. Tourism: Supports the development of AI-generated digital guides and avatars for enhanced engagement. Corporate Services: Enhances customer interaction with AI-generated service assistants. Social Media: Enables content personalization through AI face-swapping and dynamic visuals. This broad applicability makes the platform a valuable asset for businesses and institutions seeking to scale content production while maintaining high visual quality and creative flexibility. The global market for AI-generated content is rapidly expanding, driven by increasing demand in digital marketing, entertainment, and e-commerce. Unique selling points include the ability to quickly generate high-quality visuals and the flexibility to adapt to various industries. This technology significantly improves both the efficiency and quality of digital art creation by offering a highly versatile and accessible platform. Designed with usability in mind, it empowers users—regardless of technical background—to generate professional-grade visual content with ease. Compared to existing state-of-the-art solutions, this platform distinguishes itself through its broader suite of features, deeper customization capabilities, and seamless integration of AI-driven tools, making it a comprehensive solution for modern digital content creation needs. Unlike existing tools that specialize in one function, this platform is built as an end-to-end creative engine: More Than MidJourney: Offers editing, not just generation. Simpler Than Stable Diffusion: User-friendly UI with powerful controls. Smarter Than DALL·E: Beyond text-to-image—includes video and post-editing features.   AI Art, Text-to-Image, Image-to-Image, Digital Art, Art Creation Platform Infocomm, Artificial Intelligence

Globally, the average daily salt intake is 10.8g—more than twice the WHO’s recommended limit—leading to widespread health issues. In Singapore, 90% of residents consume nearly double the recommended sodium intake, contributing to prevalent health concerns like hypertension and dyslipidemia. Reducing sodium intake is a cost-effective way to enhance public health. However, simply lowering salt content arbitrarily can result in an unacceptably bland taste and compromised flavor stability. Potassium chloride (KCl) is commonly used as a salt substitute, but it has a bitter aftertaste and poses potential health risks, particularly for individuals with kidney disease or those on specific medications. This technology aims to reduce sodium intake with a natural rice umami extract, developed using advanced sodium reduction technology without MSG or alternatives(KCI). This innovative approach amplifies the salty taste sensation, and ensures the natural umami of rice is extracted to its fullest potential. As a result, this technology not only enhances flavor delivery but also promotes healthier consumption by reducing sodium intake without compromising taste. 80% Lower Sodium Content Compared to Regular Salt Sodium content in regular salt: 38,758 mg per 100g Sodium content in Low-Sodium Rice Salt: 7,391 mg per 100g Fine-Powderization Technology Utilizing optimized data-driven processing, the technology increases the surface area of salt particles that come into contact with taste buds, enhancing solubility and delivering a clean salty taste perception with less sodium. Natural Umami Extracted from Korean Rice Through advanced extraction technology, a deep, toasty umami flavor is naturally derived from Korean rice. Free from artificial flavors and additives, this enhances the depth and richness of dishes with a clean, natural taste.   Two other natural salt alternatives are available: Wasabi salt made from Korean wasabi leaves cultivated with eco-friendly method 65% Lower Sodium Content Compared to Regular Salt (3,737mg sodium per 100g) Shrimp salt made from Korean wild shrimp 73% Lower Sodium Content Compared to Regular (10,524mg sodium per 100g) The Low-Sodium Rice Salt is designed for both B2C and B2B markets, offering a wide range of applications across different industries. B2C Applications : Premium table salt in high-end grocery stores and department stores. B2B Applications : Salt pack for meal kits, ready-to-drink (RTD) products, and home meal replacement (HMR) finished products. Utilized as a low-sodium seasoning for healthy snacks. Incorporation into fine dining and restaurant menus, enhancing dishes with its low-sodium content and natural umami flavor. Replacing regular salt with this technology will allow consumers to enjoy their food with full flavour and reduced sodium intake, unlike other sodium reduction alternatives like MSG or KCl. Food, Salt, Low-Sodium, Natural Condiments, Natural Umami, Natural Flavours, Rice Extract Foods, Ingredients, Sustainability, Food Security

Facing the dual challenge of high energy consumption and the need for effective air purification in urban environments, this solution optimizes air filtration in HVAC systems. By employing advanced sound wave technology, the specialized emitter agglomerates fine airborne particles, making them easier to capture and significantly reducing the pressure drop across air handling units. This method not only lowers energy usage but also extends filter lifespan, cutting operational costs and maintenance needs. Ideal for building operators and industries that prioritize energy efficiency and superior indoor air quality, such as commercial real estate, hospitals, and manufacturing facilities, this system meets stringent G4 filtration standards and achieves performance levels equivalent to MERV 13 and MERV 14 filters.  The technology presents a cost-effective solution that significantly enhances HVAC performance and air quality, positioning itself as a sustainable investment for facilities dedicated to optimizing operational efficiency and environmental health. It improves motor energy consumption by up to 45%, while also enhancing air quality and reducing operational costs in HVAC systems. The technology owner is actively seeking collaboration partners for research and development, as well as opportunities for test-bedding within the HVAC systems field to enhance indoor air quality. Patented Emitters: Positioned along the edges of the system’s frame, these emitters work in tandem with the filter core to reduce pressure drop and enhance filtration efficiency. By altering the path of particulate matter (PM) using sound waves, the system requires less fan power to deliver the same volume of clean air, resulting in significant energy savings. Filter Media: High-quality synthetic media designed with environmental sustainability in mind. Efficiency: G4-rated performance, with MERV 13/14 efficiency validated through rigorous testing. Healthcare: Ensure sterile environments with advanced air purification and energy Saving capabilities Entertainment, Hospitality, and Education: Reduce energy consumption and improve air quality for public spaces. Construction and Real Estate: Improved HVAC performance in commercial buildings. Data Centre: Demanding Eco-energy solutions to enhance CRAC, Fan Wall, HVAC system energy reduction. Manufacturing: Efficient air filtration in industrial settings. The global market for advanced air filtration systems is robust, valued at approximately USD 4 billion and experiencing rapid growth. These systems enhance filtration efficiency by 50% and reduce pressure drops by up to 70%, significantly improving HVAC performance and energy savings. They also allow fan motors to lower energy consumption by up to 50%, maintaining optimal air quality. With an 80% increase in filtration efficiency, these technologies effectively capture more airborne pollutants, offering superior air purification compared to similar market solutions.  This advanced air filtration technology significantly outperforms traditional systems by utilizing sonic vibration to extend the travel distance of airborne particles, enhancing their capture by filter fibres for a 50% boost in filtration efficiency. Additionally, it reduces pressure drops across air handling units, enabling up to 50% energy savings and lowering operational costs while supporting sustainability goals. The UVP lies in its patented sound wave technology that uniquely alters the path of particulate matter, delivering unmatched performance and energy efficiency. This makes the system versatile for use in diverse settings like hospitals, data centres, and commercial buildings. energy saving, hvac, air quality, esg, green building, air filtration, carbon emission, filtration Environment, Clean Air & Water, Filter Membrane & Absorption Material, Sustainability, Sustainable Living

Currently flour, gelatin, butter, and sugar are commonly employed as binding agents in various culinary applications, such as nut bars, waffles, and fried food batters. However, this conventional practice raises significant concerns regarding health implications (gluten allergy, lactose intolerant)  and sustainability. This technology is a novel Konjac-based alternative to supplant conventional binding agents, which is diabetic-friendly, gluten-free and has a low calorie content. This healthy and powerful dietary binder allows the user to design various shapes and textures of foods and can be used in recipes for consumers with dietary restrictions. Able to bind and mould different ingredients together. Able to modify other ingredients' textures. Able to withstand extreme temperature from -20 ° to 121° and maintain the shape and texture of the product, which is more versatile than agar and gelatin. Free of preservatives, mixture needs to be stored cool or vacuum packed The potential applications of this Konjac-based product offer several solutions to dietary restrictions worldwide. It can replace ingredients such as sugar as a binder for diabetic or health-conscious individuals, as well as gelatin and butter to make recipes vegan-friendly. It is easy to integrate into the conventional food manufacturing processes, suitable for all culinary applications from large production to small kitchens. This product can be used by medical professionals to minimize their workload and make it possible for them to accommodate a patient's dietary restrictions without compromising the patient's health or taste. The Current Market size for the Food Binders Market is about $7.41 billion USD and is projected to reach $13.12 billion USD in 2030.  This intellectual property can be easily incorporated into any kind of operation especially the health food industry, making it easily accessible, without comprising any health implication to aid medical professionals and could influence the food substantiality market for a better outcome. Using the product will not affect the taste of the other ingredients More versatility in application, addressing challenges in process parameters and dietary restrictions,  Maintain the texture and shapes for a longer time than traditional food binders   Konjac, Dietary Binder, Future Food, Food Texture, Food Shape Personal Care, Nutrition & Health Supplements, Foods, Ingredients